Details of the Drug
General Information of Drug (ID: DMDGKFV)
Drug Name |
4-Hydroxy-pentanoic acid
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
4-Hydroxypentanoic acid; 4-Hydroxyvaleric acid; 4-hydroxy-pentanoic acid; gamma-Hydroxyvaleric acid; 13532-37-1; 4-hydroxy-valeric acid; Pentanoic acid, 4-hydroxy-; 103712-26-1; Pentanoic acid, 4-hydroxy-, (S)-; EINECS 236-884-1; ACMC-20m6jh; AC1Q5VUF; Pentanoic acid,4-hydroxy-; AC1L3FK5; AC1Q2BV5; SCHEMBL27394; CHEMBL169219; CTK4B9757; FMHKPLXYWVCLME-UHFFFAOYSA-N; MolPort-006-120-502; LMFA01050009; AKOS008148154; MCULE-6352217997; TX-017030
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 118.13 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | -0.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||